Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Inventory (2020 - 2025)

Journey Medical (DERM) has disclosed Change in Inventory for 6 consecutive years, with -$1.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory fell 149.21% year-over-year to -$1.0 million, compared with a TTM value of $30000.0 through Sep 2025, down 96.07%, and an annual FY2024 reading of $4.2 million, up 206.88% over the prior year.
  • Change in Inventory was -$1.0 million for Q3 2025 at Journey Medical, down from $356000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $12.0 million in Q2 2021 and bottomed at -$2.7 million in Q3 2021.
  • Average Change in Inventory over 5 years is $230157.9, with a median of -$823000.0 recorded in 2022.
  • The sharpest move saw Change in Inventory tumbled 1223.81% in 2023, then soared 423.11% in 2024.
  • Year by year, Change in Inventory stood at -$1.8 million in 2021, then skyrocketed by 38.87% to -$1.1 million in 2022, then grew by 23.62% to -$818000.0 in 2023, then skyrocketed by 423.11% to $2.6 million in 2024, then tumbled by 139.12% to -$1.0 million in 2025.
  • Business Quant data shows Change in Inventory for DERM at -$1.0 million in Q3 2025, $356000.0 in Q2 2025, and -$1.9 million in Q1 2025.